Generic Imatinib Therapy among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice

This observational study was conducted to assess the efficacy and safety of generic imatinib in 91 patients with chronic myeloid leukemia (either treated first-line or switched from patented to generic imatinib). Efficacy and safety of generic imatinib was comparable to patented imatinib. These results support the use of generic imatinib to reduce healthcare expenditure per patient and increase patient access.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research